Fenwal Secures New FDA Clearance for Device Designed to Help Increase Plasma Available for Transfusion
3/20/2013 7:04:07 AM
LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fenwal Inc., a Fresenius Kabi company, announced today it has received clearance from the U.S. Food and Drug Administration for a functionally closed disposable set used on the Fenwal Autopheresis-C® system to collect plasma for processing into Fresh Frozen Plasma. The Autopheresis-C system is used worldwide to collect plasma from human donors. Plasma, the liquid portion of blood, is either frozen for future transfusion, or processed by pharmaceutical companies into a range of therapies made from plasma-derived proteins.
comments powered by